tecartus
kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - linfoma, célula del manto - agentes antineoplásicos - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).
abecma
bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - agentes antineoplásicos - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
diarakor 60/12.5mg tableta recubierta
stendhal peru s.a. - tableta recubierta - por tableta - antagonistas de angiotensina ii, monodrogas
diarakor 120+12.5 tableta recubierta
stendhal peru s.a. - tableta recubierta - por tableta - antagonistas de angiotensina ii, monodrogas
ceftazidima rivero
p.l. rivero y cia s.a. - ceftazidima - inyectable - ceftazidima (como pentahidrato) 1 g / fco amp
lopresor 100 mg comprimidos recubiertos con pelicula
casen recordati s.l. - metoprolol tartrato - comprimido recubierto con pelÍcula - 100 mg - metoprolol tartrato 100 mg - metoprolol
botox onabotulinumtoxin a 50 u polvo para solucion inyectable.
merck, s.a. - onabotulinumtoxin a - polvo - 50 u
mycapssa
amryt pharmaceuticals dac - octreotide acetate - acromegalia - hormonas hipofisarias e hipotalámicas y análogos - mycapssa is indicated for maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment with somatostatin analogues.
alglutamin
p.l. rivero y cia s.a. - n(2)-l-alanil-l-glutamina - solucion inyectable - n(2)-l-alanil-l-glutamina 20,00 g / 100 ml